cracker of a study by roland diel md

This seems to be another cracker of a study by Roland Diel MD.

”The use of either IGRA as a replacement for the TST would decrease the number of LTBI suspects to be investigated by approximately 70%.”



First published online on November 18, 2008
Chest, doi:10.1378/chest.08-2048


Comparative Performance of Tuberculin Skin Test, QuantiFERON-TB-Gold In Tube Assay, and T-Spot.TB Test in Contact Investigations for Tuberculosis
Roland Diel, MD, MPH; Robert Loddenkemper, MD, FCCP; Karen Meywald-Walter, MD; Rene Gottschalk, MD and Albert Nienhaus, MD, MPH

From the School of Public Health (Dr. Diel), Heinrich Heine University of Düsseldorf, Düsseldorf; German Central Committee Against Tuberculosis (Dr. Loddenkemper), Lungenklinik Heckeshorn, HELIOS, Klinikum Emil von Behring, Berlin; Public Health Department Hamburg-Central (Dr. Meywald-Walter), Hamburg; Institute of Medical Virology (Dr. Gottschalk), University Hospital, Johann Wolfgang Goethe University, Frankfurt am Main; and Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services (Dr.
[email protected]
Abstract

RationaleMycobacterium tuberculosis (MTB)-specific interferon- release assays (IGRAs) are an alternative or adjunct to the tuberculin skin test (TST) in identifying recent contacts with latent tuberculosis infection (LTBI), but there are scarce data directly comparing performance of the tests.

Objective To evaluate the agreement between both IGRAs and to determine which contacts were most likely to represent LTBI, the QuantiFERON-TB-Gold In Tube assay (QFT) and the T-Spot.TB test (T-Spot) were compared in TST-positive persons recently exposed to pulmonary tuberculosis cases.
MethodsProspectively enrolled close contacts (n = 812) of 123 culture-confirmed tuberculosis source cases underwent IGRA testing using standardized collected data. Factors independently influencing the risk of MTB infection and their interactions with each other were evaluated by multivariate analysis.

Results Five variables were found to significantly predict a positive IGRA test result (age, source case acid-fast bacilli positive and/or coughing, cumulative exposure time, foreign origin). There was excellent agreement between the two IGRAs (93.9%, = 0.85), with QFT finding 30.2% of contacts positive and T-Spot finding 28.7%. Assuming positivity to both IGRAs as true infection, sensitivity of the TST at 10 mm was 72% and at 15 mm was 39.7%. The use of either IGRA as a replacement for the TST would decrease the number of LTBI suspects to be investigated by approximately 70%.

Conclusions IGRAs are a more accurate indicator of the presence of LTBI than the TST. Both QFT and T-Spot appear to be valuable public health tools, showing excellent agreement with each other.

Key Words: independent risk factor • interferon- release assay • latent infection • tuberculin skin test • tuberculosis
Wr
Tu

http://www.chestjournal.org/cgi/content/ab...chest.08-2048v1